Clinical Scenario

This protocol covers balanoposthitis caused by a candidal (fungal) aetiology. Candidal balanoposthitis represents a distinct subset of balanoposthitis cases, accounting for fewer than one in five presentations, and requires a targeted antifungal strategy rather than a general approach.

Treatment Approach

Management is based on topical antifungal therapy. The choice of agent is guided by individual clinical factors, including whether resistance or hypersensitivity to a particular antifungal class is a consideration. An oral antifungal is an option when symptom severity warrants it, and a combined anti-inflammatory preparation may be appropriate when significant local inflammation is present alongside the infection.

Full agent selection, sequencing, and any additional considerations are set out in the complete protocol.

References

Candidal balanoposthitis (<20% of cases)
Clotrimazole cream 1% (1,C) Apply twice daily for 7–14 days.
Fluconazole 150 mg orally (1,C) — if symptoms severe
Miconazole cream 2% (2,B)
Nystatin cream 100,000 units/g — if resistance suspected, or allergy to imidazoles (2,B)
Topical imidazole with 1% hydrocortisone — if marked inflammation is present (2,D)

DOI: 10.1111/jdv.18954

View source ↗

Treatment of Balanoposthitis in Candidal Balanoposthitis

References